Zygomycosis

Download PDF

Recent Publications on Zygomycosis:
Primary cutaneous mucormycosis in a lung transplant recipient: case report and concise review of the literature. Mucormycosis (zygomycosis) is an invasive, opportunistic fungal infection...	17th July, 2008	Division of Infectious Diseases, University Health Network, University of	Transpl Infect Dis. 2008 Jun 24;. DOI Direct Link
Recurrence of primary hyperoxaluria: An avoidable catastrophe following kidney transplant. Primary hyperoxaluria is a rare autosomal recessive disease due to...	16th July, 2008	Department of Pathology, Seth GS Medical College and KEM Hospital, Acharya	J Postgrad Med. 2008 Jul-Sep;54(3):206-8.
Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. BACKGROUND: Zygomycosis is an emerging opportunistic mycosis among...	10th July, 2008	Department of Infectious Diseases, Infection Control and Employee Health,	Clin Infect Dis. 2008 Aug 15;47(4):503-9. DOI Direct Link
Gastrointestinal zygomycosis due to Rhizopus microsporus var. rhizopodiformis as a manifestation of chronic granulomatous disease. A case of gastrointestinal zygomycosis in a 10-month-old boy with chronic...	9th July, 2008	Departments of Pediatrics, Nijmegen, The Netherlands.	Med Mycol. 2008 Mar 12;:1-4. DOI Direct Link
Recommendations for the treatment of established fungal infections. Evidence-based guidelines for the treatment of established fungal...	1st July, 2008	Department of Infectious Diseases, Peter MacCallum Cancer Centre and St	Intern Med J. 2008 Jun;38(6b):496-520. DOI Direct Link
→View more research publications.

Zygomycosis Clinical Trials:
Phase II Trial of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis Treatment	Zygomycosis Intervention: Drug: Liposomal Amphotericin B

Zygomycosis Patents:
US Patent No.	Title
5534251	Stabilized il-1.alpha. medicinal composition
6541224	Tumor necrosis factor delta polypeptides
6562579	Diagnostic methods using antibodies to Neutrokine-alpha
6623941	Nucleic acids encoding human tumor necrosis factor TR20
6627408	Antifungal assay
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Zygomycosis scientists - we have details of around 63 individuals working on Zygomycosis .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.